GPCR-mediated natural products and compounds: Potential therapeutic targets for the treatment of neurological diseases

被引:0
|
作者
Wang, Xing Xia [1 ,2 ]
Ji, Xiang [1 ]
Lin, Jing [3 ]
Wong, Io Nam [5 ]
Lo, Hang Hong [1 ]
Wang, Jian [4 ]
Qu, Liqun [1 ]
Wong, Vincent Kam Wai [1 ]
Chung, Sookja Kim [1 ,5 ]
Law, Betty Yuen Kwan [1 ]
机构
[1] Macau Univ Sci & Technol, Nehers Biophys Lab Innovat Drug Discovery, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Southwest Med Univ, Affiliated Hosp, Dept Neurol, Luzhou, Sichuan, Peoples R China
[3] Luzhou Hosp Tradit Chinese Med, Dept Endocrinol, Luzhou, Sichuan, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Affiliated Canc Hosp, Sichuan Clin Res Ctr Canc,Sichuan Canc Ctr,Dept Me, Chengdu, Peoples R China
[5] Macau Univ Sci & Technol, Fac Med, Macau, Peoples R China
关键词
Natural products; G protein-coupled receptors; Central nervous system; Neurological disorders; PROTEIN-COUPLED RECEPTORS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; JITAI TABLETS; DOUBLE-BLIND; RAT MODEL; IN-VITRO; DOPAMINE; PHARMACOLOGY;
D O I
10.1016/j.phrs.2024.107395
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs), widely expressed in the human central nervous system (CNS), perform numerous physiological functions and play a significant role in the pathogenesis of diseases. Consequently, identifying key therapeutic GPCRs targets for CNS-related diseases is garnering immense interest in research labs and pharmaceutical companies. However, using GPCRs drugs for treating neurodegenerative diseases has limitations, including side effects and uncertain effective time frame. Recognizing the rich history of herbal treatments for neurological disorders like stroke, Alzheimer's disease (AD), and Parkinson's disease (PD), modern pharmacological research is now focusing on the understanding of the efficacy of traditional Chinese medicinal herbs and compounds in modulating GPCRs and treatment of neurodegenerative conditions. This paper will offer a comprehensive, critical review of how certain natural products and compounds target GPCRs to treat neurological diseases. Conducting an in-depth study of herbal remedies and their efficacies against CNS-related disorders through GPCRs targeting will augment our strategies for treating neurological disorders. This will not only broaden our understanding of effective therapeutic methodologies but also identify the root causes of altered GPCRs signaling in the context of pathophysiological mechanisms in neurological diseases. Moreover, it would be informative for the creation of safer and more effective GPCR-mediated drugs, thereby establishing a foundation for future treatment of various neurological diseases.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets
    Zhao, Jia
    Wang, Di
    Cui, Wei
    Chen, Hansen
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [2] Mitochondria as therapeutic targets for Natural Products in the treatment of Cardiovascular Diseases
    Yang, Yanze
    Owusu, Felix Boahen
    Wu, Han
    Zhang, Xinyue
    Li, Ruiqiao
    Liu, Zhanbiao
    Zhang, Shaozhuo
    Leng, Ling
    Wang, Qilong
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 345
  • [3] Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug
    Xu, Zheng
    Shao, Zhenhua
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [4] Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug
    Zheng Xu
    Zhenhua Shao
    Signal Transduction and Targeted Therapy, 7
  • [5] Cardiac GPCR-Mediated EGFR Transactivation: Impact and Therapeutic Implications
    Grisanti, Laurel A.
    Guo, Shuchi
    Tilley, Douglas G.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2017, 70 (01) : 3 - 9
  • [6] Therapeutic potential of natural products and underlying targets for the treatment of aortic aneurysm
    Zhao, Wenwen
    Li, Bufan
    Hao, Jinjun
    Sun, Ruochen
    He, Peng
    Lv, Hongyu
    He, Mou
    Shen, Jie
    Han, Yantao
    PHARMACOLOGY & THERAPEUTICS, 2024, 259
  • [7] Potential therapeutic targets in polyglutamine-mediated diseases
    Katsuno, Masahisa
    Watanabe, Hirohisa
    Yamamoto, Masahiko
    Sobue, Gen
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (10) : 1215 - 1228
  • [8] Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules
    Miller, John H.
    Das, Viswanath
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (35) : 4362 - 4372
  • [9] Autophagy and cardiac diseases: Therapeutic potential of natural products
    Wu, Xiaoqian
    Liu, Zumei
    Yu, Xi-Yong
    Xu, Suowen
    Luo, Jiandong
    MEDICINAL RESEARCH REVIEWS, 2021, 41 (01) : 314 - 341
  • [10] Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders
    Karim, Nasiara
    Abdelhalim, Heba
    Gavande, Navnath
    Khan, Imran
    Khan, Haroon
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018